Related Experiment Video
Updated: Jul 17, 2026

A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
[Sympathomimetic syndrome caused by autointoxication with methylphenidate]
L F D van Vulpen1, M M Malingré, R Lange
1Afd. Interne Geneeskunde, Meander Medisch Centrum, Postbus 1502, 3800 BM Amersfoort.
A man survived a massive overdose of methylphenidate (a stimulant) and alcohol. Prompt treatment with activated charcoal and supportive care led to a full recovery from this potentially lethal poisoning.
Area of Science:
- Toxicology
- Pharmacology
- Emergency Medicine
Background:
- Methylphenidate is a central nervous system stimulant commonly prescribed for ADHD.
- Co-ingestion of substances can complicate overdose management and prognosis.
Observation:
- A 31-year-old male presented after ingesting over 1000 mg of methylphenidate, 8000 mg of ibuprofen, and significant alcohol.
- Clinical signs included agitation, hallucinations, mydriasis, and sinus tachycardia, indicative of a sympathomimetic syndrome.
Findings:
- Toxicological analysis revealed a plasma-ethanol concentration of 0.27% and a peak serum-methylphenidate level of 176 µg/l.
- Toxic concentrations of ethylphenidate, an active metabolite, were also detected.
- The patient received activated charcoal and an oral laxative, followed by intensive care unit observation.
Implications:
- This case highlights the importance of prompt medical intervention in severe methylphenidate overdose.
- Management strategies include preventing further absorption, close monitoring of vital signs, and supportive care.
- The presence of ethylphenidate underscores the complex metabolism and potential toxicity of methylphenidate co-ingestion.
Related Concept Videos
Toxidromes: Clinical Features
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Adrenergic Agonists: Indirect-Acting Agents
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
CNS Stimulants: Psychedelic Agents

